Turkey Health Minister Tells Envoy Access To U.S. Drug Market Would Pave Way For Import Review
This article was originally published in PharmAsia News
Executive Summary
The Turkish health ministry has turned the tables in response to a complaint by the U.S. ambassador on the time it takes to get a license to import drugs. Global drug companies have stepped up complaints on the import process since a GMP certificate from Turkey’s health ministry became mandatory in 2010.